Oct 10 (Reuters) - California-based diagnostics company Bio-Rad Laboratories is in talks to merge with Qiagen NV , according to a Wall Street Journal report on Monday. (Reporting by Bhanvi Satija in Bengaluru; Editing by Vinay Dwivedi)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.08 USD | -1.06% | +4.08% | -8.25% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.25% | 9.09B | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+45.26% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- QGEN Stock
- News Qiagen N.V.
- Diagnostics firm Bio-Rad in talks to merge with Qiagen - WSJ